Acetaminophen: 4 Things to Know About This Common Over-the-Counter Drug

The FDA recently issued a warning regarding liver damage caused by acetaminophen. Here are four things consumers and investors need to know about the drug, and how it could affect companies like Johnson & Johnson, Novartis, GlaxoSmithKline, and Zogenix.

Jan 21, 2014 at 10:15AM

The Food and Drug Administration recently issued a warning regarding higher doses of acetaminophen, the active ingredient in over-the-counter painkillers such as Johnson & Johnson's (NYSE:JNJ) Tylenol, Novartis' (NYSE:NVS) Excedrin, and GlaxoSmithKline's (NYSE:GSK) Panadol.

The warning follows a new report showing that acetaminophen sends 78,000 Americans to the emergency room and causes more than 1,500 accidental deaths annually.

Let's take a look at four key things that consumers and investors should know about acetaminophen and how the FDA warning could affect companies like J&J, Novartis, GSK, and Zogenix (NASDAQ:ZGNX).

1. What is acetaminophen?
Acetaminophen belongs to a class of painkillers called non-opioid analgesics, which also includes aspirin and ibuprofen.

Acetaminophen is generally more potent than aspirin or ibuprofen since it directly affects the central nervous system (brain and spinal cord nerves), rather than the peripheral nervous system that is treated by aspirin and ibuprofen. This makes acetaminophen an ideal treatment for headaches, fever, and minor body aches.

The big drawback of acetaminophen is the possibility of liver damage in higher doses. Back in 2009, the FDA identified that risk and required drugs like Tylenol to carry an additional warning label.

The new FDA warning urges caution in medications containing more than 325 mg of acetaminophen, with a recommended daily limit of 4,000 mg. For reference, a single tablet of Extra Strength Tylenol contains 500 mg of acetaminophen -- which means just eight tablets would hit the safety threshold. In addition, consuming 1,000 mg (two tablets) at once is also considered dangerous.

2. What other medications contain acetaminophen?
Although Tylenol has gotten the most attention due to its prevalent use in the United States, many other drugs also contain acetaminophen.

Other over-the-counter drugs, such as Novartis' Excedrin, J&J's Sudafed, and Bayer's (NASDAQOTH:BAYRY) Alka-Seltzer Cold and Sinus also contain acetaminophen. GSK's Panadol, which is widely available in the U.K., Europe, Middle East, and Asia, contains similar doses of acetaminophen (paracetamol) as Tylenol.

More potent prescription painkillers such as Vicodin and Percocet also contain varying amounts of acetaminophen.

Image

Tylenol, one of the most popular acetaminophen painkillers in the United States. Source: Wikimedia.

3. What are the alternatives to acetaminophen?
Despite the current concerns about acetaminophen, drugs like Tylenol, Panadol, and Excedrin are safe in normal doses.

In fact, they are widely considered safer alternatives to non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and aspirin, which are known to cause stomach and heart problems in some patients.

However, since acetaminophen is not an anti-inflammatory drug, it is considered less effective at treating muscle inflammation than ibuprofen or aspirin.

Since moderate doses of acetaminophen are considered safe, there aren't any comparable over-the-counter alternatives except for NSAIDs. Some drugs combine acetaminophen with NSAIDs. Excedrin, for example, is a combination of acetaminophen, aspirin, and caffeine. 

4. What role does acetaminophen play in prescription drugs?
On the prescription side of things, however, acetaminophen's liver damage issue has sparked a debate regarding the use of narcotic painkillers.

Vicodin, for example, is a mix of the narcotic painkiller hydrocodone and acetaminophen. By itself, hydrocodone can cause gastrointestinal problems, emotional instability, skin problems, and respiratory issues. It is also addictive and has been abused for recreational purposes. Acetaminophen is added to Vicodin to offset the side effects of hydrocodone.

Depending on the specific formulation of Vicodin, it can contain 300 mg to 750 mg of acetaminophen and 2.5 mg to 10 mg of hydrocodone. Vicodin's acetaminophen content has led to criticism that the drug could cause liver damage.

That's where Zogenix's Zohydro ER comes in. Zohydro ER, which was approved last October, is an extended release version of hydrocodone without acetaminophen. As a result, Zohydro can be 10 times as potent as Vicodin, which has worried drug abuse experts across the country.

Zogenix believes that Zohydro will provide more effective pain relief than Vicodin without the risk of liver damage from acetaminophen, but critics point out that Zohydro ER isn't tamper resistant and can be crushed or dissolved into alcohol for recreational use.

Meanwhile, Percocet, a similar drug to Vicodin that combines the narcotic painkiller oxycodone with acetaminophen, has been criticized for the same reasons. Purdue Pharma's OxyContin, which is oxycodone without acetaminophen, was implicated along with hydrocodone in thousands of deaths between 1998 and 2008.

The Foolish takeaway
In conclusion, acetaminophen is safe when taken in moderation and without alcohol.

Despite the FDA's concerns, acetaminophen is still a preferable alternative to NSAIDs in over-the-counter drugs, and helps decrease the potential for abuse in prescription medications such as Vicodin and Percocet.

What are your concerns about acetaminophen? Please share your thoughts in the comments section below!

Want to know more about the health-care industry and Obamacare?Obamacare seems complex, but it doesn't have to be. In only minutes, you can learn the critical facts you need to know in a special free report called "Everything You Need to Know About Obamacare." This FREE guide contains the key information and money-making advice that every American must know. Please click here to access your free copy.

Fool contributor Leo Sun has no position in any stocks mentioned. The Motley Fool recommends and owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at www.fool.com/podcasts.

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to www.fool.com/podcasts, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.

 


Compare Brokers